Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06414083 · ClinicalTrials.gov registry record · NA
Histologic Comparison of Ablative Techniques for Endometriosis
A NA study of Endometriosis and Endometriosis-related Pain, sponsored by TriHealth.
- Recruiting
- Registry status
- NA
- Development phase
- 141
- Enrollment target
- 1
- Study location
NCT06414083: Recruiting NA study of Endometriosis and Endometriosis-related Pain, sponsored by TriHealth.
NCT06414083 is a NA study of Endometriosis and Endometriosis-related Pain that is actively recruiting participants, run by TriHealth. The registered enrollment target is 141 participants, below the 261-participant average among 48 other Endometriosis trials with a reported enrollment target (46% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06414083, a NA study of Endometriosis and Endometriosis-related Pain, is actively recruiting participants, sponsored by TriHealth.
- RECRUITING
- Registry status
- NA
- Development phase
- 141 participants
- Enrollment target
- 1
- Study location
Study Summary
To our knowledge, no other human studies directly compare the effectiveness of the various ablative technologies. We set out to design a study to directly compare ablative energy sources and evaluate their ability to destroy native endometriosis tissue in humans.
Primary Outcome
Endometriosis seen on pathologic sample.
Conditions Studied
Interventions
- DEVICE CO2 Laser
- DEVICE Diathermy
- DEVICE Argon Beam Coagulator
Study Locations (1)
Ohio
- Good Samaritan Hospital - Cincinnati
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 141 participants |
| Start Date | 2024-05-09 |
| Est. Completion | 2025-06-09 |
| Phase | NA |
What NCT06414083 shows while recruiting
NCT06414083 is an interventional study that assigns participants to a tested intervention. The registered 141 participants enrollment target is mid-sized for trials with a published cap, below the 261-participant average among 48 other Endometriosis trials with a reported enrollment target (46% lower).
The record links to 4 conditions, with Endometriosis appearing as the primary indexed condition, and to 3 interventions - of which CO2 Laser is the first listed.
NCT06414083 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT06414083 about?
NCT06414083 is a clinical study titled "Histologic Comparison of Ablative Techniques for Endometriosis". To our knowledge, no other human studies directly compare the effectiveness of the various ablative technologies. We set out to design a study to directly compare ablative energy sources and evaluate their ability to destroy native endometriosis tissue in humans.
What is the current status of trial NCT06414083?
This trial is currently recruiting. It is a NA study. The enrollment target is 141 participants. The study started on 2024-05-09. Estimated completion is 2025-06-09.
What conditions does trial NCT06414083 study?
This clinical trial studies the following conditions: Endometriosis, Endometriosis-related Pain, Endometriosis Pelvic, Endometriosis; Peritoneum.
What interventions are being tested in trial NCT06414083?
The interventions under investigation include: CO2 Laser (DEVICE), Diathermy (DEVICE), Argon Beam Coagulator (DEVICE).
Who is sponsoring clinical trial NCT06414083?
This trial is sponsored by TriHealth, which has 81 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06414083 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Endometriosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06414083's enrollment target sits among peer trials
141 13th of 48 higher than 36 of 48 other Endometriosis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Endometriosis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Interdisciplinary Group Care for the Treatment of Endometriosis-associated Pain
RECRUITING · NA
-
The Impact of Yoga on Endometriosis-Related Pain
RECRUITING · NA
-
Physical Therapy After Endometriosis Excision
RECRUITING · NA
-
Comparison of Proton or Intensity Modulated Radiation Therapy After Surgery for Endometrial or Cervical Cancer
RECRUITING · NA
-
Hugo™ Robotic-Assisted Surgery (RAS) System in Gynecological Subjects (Embrace Gynecology)
RECRUITING · NA
-
Remote Electrical Stimulation as a Long-term Intervention for Endometriosis Flare Ups
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03042962 · 141 participants
Brain Networks in Dystonia
- NCT04378439 · 141 participants · NA
Appalachian Partnership to Reduce Disparities (Aim 2)
- NCT04775485 · 141 participants · Phase 2
A Study to Evaluate Tovorafenib in Pediatric and Young Adult Participants With Relapsed or Progressive Low-Grade Glioma and Advance Solid Tumors
- NCT05040360 · 141 participants · Phase 2
Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendocrine Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI